Biological structures proof

Menopause is biological evidence of aging in women. The absence of menstruation is clinical evidence of the inability of individual females to reproduce. However, what seems to be bad news is in fact proof that individual women can protect themselves. The reproductive process in the female is a very demanding one, and, consequently, nature has provided a mechanism to interrupt reproductive activity when biologic structures giving support to pregnancy enter the aging process. Conversely, in the male, whose participation in reproduction is limited both in time and resources, such a limitative mechanism does not exist. 

Thus, it is the intent to limit attention here to the phospholipids and to their interrelation with other components of membranes and with each other examples of their participation in biologically important reactions will be explored. Prior to an in-depth treatment of the chemistry of the phospholipids, it seemed appropriate to describe some general facets of their biochemistry, especially with regard to approaches to isolation, purification, structure proof, and so on. In addition, it is appropriate to include a very brief resume of the types of fatty acids commonly found in naturally occurring lipids because it will complement later discussions on the complex phospholipids. 

Isolation of complex molecules in low yields presents challenges in structure elucidation. In all cases, as illustrated above, our structure elucidation of cyanobacterial-derived dolastatins would have been greatly hampered without their isolation in good yields or prior structural proofs of the seahare-derived metabolites. This clearly highlights the importance of correctly identifying the true biological origin of metabolites of interest. 

During the course of synthesis and structure proof of the leukotrienes, it was important to synthesize the four optical isomers derivable from the two asymmetric centers at C-5 and C-6 of the eicosatetraeonic acid chain in order to fully confirm that the natural compounds had the (5S,6/ ) configuration. It was also of considerable scientific interest to find out what effect changes in configuration on these centers would have upon the biological activity of the compounds. 

When my own papers are reviewed, I appreciate cogent comments on the argument being presented for a compound structure proof, as well as any perceived deficiencies in the chemical or biological approaches being applied to the problem at hand. Comments that are factually incorrect, illogical, or personal in nature are not usually valuable. 

There was general agreement that total synthesis still does have intrinsic value as a method of structure proof in many cases, particularly where stereochemistry is involved. It was also recognized that it is sometimes the only way to obtain sufficient amounts of rare natural products with which to carry out biological experiments. 

In molecular pharmacology research an indirect proof of a structural model is possible by functional examinations, e.g., by molecular biological experiments. Well-selected site directed mutagenesis and their functional characterization allows confirmation or rejection of a molecular protein model. The process is organized as an iterative procedure, where the biological answer of suggested mutations is used to refine the model. The iteration continues until the model... 

Since the first description was only two decades ago, combinatorial biosynthesis has advanced from a limited set of proof-of-principle experiments into a more mature scientific discipline. To reach the maximal potential of natural product structural diversity, the combination of this approach with other established and emerging technologies will ultimately provide access to a rich variety of unnatural natural products with improved properties or new biological activities for future drug discovery and development. 

Novel biomarkers, i.e. tracer derivatives from unknown natural products, are sometimes encountered in geological or environmental samples, typically as hydrocarbons. The detection and determination of these compounds are usually based on the interpretation of mass spectra in GC-MS analyses. The proofs of chemical structures are based on the proposed interpretation of the MS data, separation and purification of the unknown compounds, exact structure determination by NMR methods or X-ray crystallography (if the compound is a solid that can be crystallized), and finally, comparison with a synthetic standard. The next question concerns the biological source of the biomarker precursor compound. Many biomarkers still have no proven natural product precursors nor known biological sources (e.g. perylene, tricyclic terpanes). " ... 

In spite of the overwhelming importance of the channel mechanism for the transport of alkali and alkaline earth metal ions in biological systems, only carrier transport has been studied extensively by chemists. Studies on ion channel mimics of simple structures have long been limited to antibiotic families of gramicidin, amphotericin B, and others. Several pioneers have reported successful preparation of non-peptide artificial channels. However, their claims have been based on kinetic characteristics observed for the release of metal ions through liposomal membrane and lacked the very critical proofs of channel formation. Such a situation was... 

The tertiary structure of a globular protein is determined by its amino acid sequence. The most important proof of this came from experiments showing that de-naturation of some proteins is reversible. Certain globular proteins denatured by heat, extremes of pH, or denaturing reagents will regain their native structure and their biological activity if returned to conditions in which the native conformation is stable. This process is called renaturation. 

---